metyrosine
- Product NDC
- 60219-1621
- 11-digit product format
- 602191621
- Labeler code
- 60219
- Product ID
- 60219-1621_d533653d-aa45-4c53-8440-08b2178e64dc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- metyrosine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA213734
- Marketing category
- ANDA
- Marketing start
- 2020-07-24
- Marketing end
- 0000-00-00
- Substance
- METYROSINE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Catecholamine Synthesis Inhibitor [EPC],Catecholamine Synthesis Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60219-1621-1 | metyrosine | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60219-1621 | METYROSINE CAPSULE [AMNEAL PHARMACEUTICALS NY LLC] | 4 | Legacy NDC, 1 package rows | 20201105_ab57037b-11ca-45c5-ac6e-deea64990375.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60219-1621-1 | 60219162101 | 100 CAPSULE in 1 BOTTLE, PLASTIC (60219-1621-1) | 100 capsule | 2020-07-24 | 0000-00-00 | No | No | Current |